SRPT
Sarepta Therapeutics, Inc. · Healthcare
Director Stephen Mayo sold $94K of Sarepta Therapeutics, Inc.
Sold$94,311
$109.92Price
858Shares
−12%Stake
What SRPT did after the filing
- The stock from Mon, Nov 21 close, $110.55
- +10.0%
- S&P 500, same days
- −3.4%
Measured over 30 trading days, to the Jan 5 close.
Traded Thu, Nov 17. Filed Mon, Nov 21, 3:00 PM ET, during the session. Returns use the Nov 21 close and the Jan 5 close. Not investment advice.